Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice

Journal of Comparative Neurology

Volumn 498, Issue 2, 2006, Pages 217-226

  Raijmakers, Reinout ^a   Vogelzangs, Judith ^a   Raats, Jos ^a,b   Panzenbeck, Maret ^c   Corby, Maureen ^c   Jiang, Huiping ^c   Thibodeau, Michael ^c   Haynes, Nancy ^c   Van Venrooij, Walther J ^a   Pruijn, Ger J M ^a   Werneburg, Brian ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ModiQuest BV   (Netherlands)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Citrulline; Experimental autoimmune encephalomyelitis; Glial fibrillary acidic protein; Multiple sclerosis; Myelin basic protein; Peptidylarginine deiminase

Indexed keywords

CITRULLINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN ARGININE DEIMINASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN MODIFICATION; WESTERN BLOTTING;

ANIMALS; CITRULLINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; HYDROLASES; ISOENZYMES; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SPINAL CORD;

EID: 33746844946     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21055     Document Type: Article

References (31)

1. Allen SJ, Baker D, O'Neill JK, Davison AN, Turk JL. 1993. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell Immunol 146:335-350.
2. Asaga H, Akiyama K, Ohsawa T, Ishigami A. 2002. Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain. Neurosci Lett 326:129-132.
3. Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G. 2000a. Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J Struct Biol 129:80-95.
4. Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G. 2000b. Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J Struct Biol 129:80-95.
5. Boggs JM, Yip PM, Rangaraj G, Jo E. 1997. Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles. Biochemistry 36:5065-5071.
6. Boggs JM, Rangaraj G, Koshy KM, Ackerley C, Wood DD, Moscarello MA. 1999. Highly deiminated isoform of myelin basic protein from multiple sclerosis brain causes fragmentation of lipid vesicles. J Neurosci Res 57:529-535.
7. Garren H, Steinman L, Lock C. 1998. The specificity of the antibody response in multiple sclerosis. Ann Neurol 43:4-6.
8. Gould RM, Freund CM, Palmer F, Feinstein DL. 2000. Messenger RNAs located in myelin sheath assembly sites. J Neurochem 75:1834-1844.
9. Hill JA, South-wood S, Sette A, Jevnikar AM, Bell DA, Cairns E. 2003. Cutting edge: the conversion of arginine to citralline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171:538-541.
10. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N, Maruyama N. 2005. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 80:120-128.
11. Juedes AE, Ruddle NH. 2001. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 166:5168-5175.
12. Mastronardi FG, Moscarello MA. 2005. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 80:301-308.
13. Moscarello MA, Wood DD, Ackerley C, Boulias C. 1994. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94:146-154.
14. Moscarello MA, Pritzker L, Mastronardi FG, Wood DD. 2002. Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem 81:335-343.
15. Nicholas AP, Sambandam T, Echols JD, Tourtellotte WW. 2004. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol 473:128-136.
16. Nicholas AP, Sambandam T, Echols JD, Barnum SR. 2005. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. J Comp Neurol 486:254-266.
17. Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA. 2000. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39:5374-5381.
18. Raats JM, Wijnen EM, Pruijn GJ, van den Hoogen FH, Van Venrooij WJ. 2003. Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J Rheumatol 30:1696-1711.
19. Raijmakers R, Vogelzangs J, Croxford JL, Wesseling P, Van Venrooij WJ, Pruijn GJ. 2005. Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis. J Comp Neurol 486:243-253.
20. Rodenburg RJ, Raats JM, Pruijn GJ, Van Venrooij WJ. 2000. Cell death: a trigger of autoimmunity? Bioessays 22:627-636.
21. Sambandam T, Belousova M, Accaviti-Loper MA, Blanquicett C, Guercello V, Raijmakers R, Nicholas AP. 2004. Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem Biophys Res Commun 325:1324-1329.
22. Senshu T, Sato T, Inoue T, Akiyama K, Asaga H. 1992. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 203:94-100.
23. Senshu T, Akiyama K, Kan S, Asaga H, Ishigami A, Manabe M. 1995. Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol 105:163-169.
24. Steinman L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299-302.
25. Tranquill LR, Cao L, Ling NC, Kalbacher H, Martin RM, Whitaker JN. 2000. Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult Scler 6:220-225.
26. Vossenaar ER, Zendman AJ, Van Venrooij WJ, Pruijn GJ. 2003. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25:1106-1118.
27. Vossenaar ER, Radstake TRD, van der Heijden A, van Mansum MAM, Dieteren C, de Rooij DJ, Barrera P, Zendman AJW, Van Venrooij WJ. 2004a. Expression and activity of citrullinating PAD enzymes in monocytes and macrophages. Ann Rheum Dis 63:373-381.
28. Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, Van Venrooij WJ, Tak PP. 2004b. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485-3494.
29. Wattler S, Kelly M, Nehls, M. 1999. Construction of gene targeting vectors from lambda KOS genomic libraries. BioTechniques 26:1150-1160.
30. Wegner C. 2005. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system. Int MS J 12:13-19.
31. Wood DD, Bilbao JM, O'Connors P, Moscarello MA. 1996. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 40:18-24.